HITLAB World Cup India 2018 set to be held at Delhi

The event being organized at Indian Institute of Technology, Delhi on February 10th, 2018, offers participants a high-profile stage to showcase their work, with up to USD 500,000 (INR 3.5 crore) in funding for winning solutions

New Delhi: The digital health technology is having a remarkable influence on healthcare access, delivery, and outcomes throughout India and the world. Its potential to transform public health for the better is truly limitless.

HITLAB, a leading digital health teaching, research, and innovation lab has opened up another fantastic opportunity for health-tech and digital health startups to help diffuse their work to improve lives. Innovators with novel solutions to healthcare challenges are invited to enter the 2018 HITLAB World Cup: India, in partnership with Unitus Seed Fund’s StartHealth initiative.

HITLAB remains determined to address healthcare challenges in India and throughout the world. The HITLAB World Cup: India is carefully constructed to advance digital health innovation in the region. The annual event provides outstanding opportunities to increase healthcare productivity, affordability, and accessibility. Most importantly, the exceptional solutions that emerge go a long way toward improving health outcomes and, in turn, lives.

The BioVoice News is the official media partner of the event. We will bring live and post post-event for our readers.

The 2018 HITLAB World Cup: India is a high-profile showcase for original health-tech solutions, where finalists will get a chance to pitch for global exposure, mentorship, and up to USD 500,000 (INR 3.5 crore) in grants and equity funding at the 2018 HITLAB Innovators Summit: India, on 10th February at Indian Institute of Technology (IIT) Delhi.

Over the past 10 years, finalists at HITLAB World Cup competitions across the globe have raised over 50 million USD.

Face to Face

Mentioned Dr Geetha Manjunath, CEO & CTO of Bangalore-based healthtech startup NIRAMAI in an exclusive interaction with BioVoice where she spoke about the artificial intelligence in healthcare and an innovative early breast cancer detection technology developed by her company...….

Subscribe Our Newsletter

Email Address

Chat with BioVoice

Mentioned Dr Debarka Sengupta in an exclusive interaction with the BioVoice, where he explained the idea and importance of FiRE, a novel algorithm that can detect rare cell types at a very fast speed developed by his team at the Indian Institute of Technology-Delhi...……….

The BioVoice is an independent media outlet for coverage of Indian bioscience sector through its 24*7 live web portal, bi-annual digital magazine and soon to be launched app. Founded in 2015, this vibrant news platform connects various dots... Read More